A regulation in the US which attempts to give seriously ill patients access to new developmental drugs as early as possible. These drugs are generally made available during phase III studies before general marketing begins.
Search and browse hundreds of industry specific terms and phrases or suggest your own terms and definitions.
A regulation in the US which attempts to give seriously ill patients access to new developmental drugs as early as possible. These drugs are generally made available during phase III studies before general marketing begins.
Related terms
Relative market share, Rate card, Trial stage, Launch, Joint venture, Abbreviated advertisement (UK), Therapy area, Marketing information, Organic growth/development, Point-of-purchase displays, Conjoint analysis, Discounted cash flow (DCF), Asset-led marketing, Methodology, Opportunities to hear (OTH),